Entera Bio Ltd. (NASDAQ: ENTX) (“Entera” or the “Company”), a leader in the development of oral peptides and proteins replacement therapies, today announced new validating in vivo pharmacokinetic and ...

When treated with KRAS inhibitors alone, cancer cells can escape destruction by using the salvage pathway to gather ...

Maddison McKee, spokesperson for Primary and Preventative Care Minister Adriana LaGrange, in a statement blamed AHS for ...

As digital platforms contend with rising levels of automated activity and declining confidence in what constitutes real user ...

Cuffless devices to measure blood pressure, such as smartwatches, rings, patches and fingertip monitors, show great promise as alternatives to traditional arm-cuff monitors, however, they are not yet ...

OS Therapies Inc. (NYSE American: OSTX) (“OS Therapies” or “the Company”), the world leader in listeria-based cancer ...

VANCOUVER, BC / ACCESS Newswire / December 23, 2025 / Relevant Gold Corp. ("Relevant Gold" or the "Company") reports that 2025 was a milestone year marked by the first drill test of the Apex orogenic ...

Testing demonstrates 48% file size reduction with robust ML model accuracy across multiple industry-standard metrics. AV teams are invited to meet Beamr at CES 2026, January 6-9 in Las Vegas ...

Leonardo DRS, Inc. (NASDAQ: DRS) announced today the successful first on-orbit test of its revolutionary multi-channel ...

ASH 2025 oral presentation on SENTI-202 in 20 Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) patients (18 response evaluable) shows high efficacy: 50% ORR and 42% CR/CRh (100% of CRs and 83% of ...

Detailed price information for Adaptive Biotechnologies Corp (ADPT-Q) from The Globe and Mail including charting and trades.

Ether (ETH) has oscillated around $3,000 for the past three weeks, a consolidation period following its flash crash to $2,620 ...